Plasma cholesterol-lowering activity of dietary dihydrocholesterol in hypercholesterolemia hamsters

Atherosclerosis

Volumn 242, Issue 1, 2015, Pages 77-86

  Wang, Xiaobo ^a   Guan, Lei ^b   Zhao, Youyou ^b   Lei, Lin ^a   Liu, Yuwei ^a   Ma, Ka Ying ^a   Wang, Lijun ^a   Man, Sun Wa ^a   Wang, Junkuan ^b   Huang, Yu ^a   Chen, Zhen Yu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b R and D Center   (China)

Author keywords

5 cholestanol; Cholesterol; Sterol; sitosterol

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ABC TRANSPORTER G5; ABC TRANSPORTER G8; ACYL COA CHOLESTEROL ACYLTRANSFERASE 2; CHOLESTANOL; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ACYLTRANSFERASE; COPROSTEROL; DEOXYCHOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; NIEMANN PICK C1 LIKE 1 PROTEIN; PROTEIN; SITOSTEROL; STEROL DERIVATIVE; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; TRIACYLGLYCEROL TRANSPORT PROTEIN; UNCLASSIFIED DRUG; BILE ACID; CHOLESTEROL INTAKE; GAMMA-SITOSTEROL; LIPID; LIPOPROTEIN; MICELLE; SITOSTEROL DERIVATIVE; STEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DOWN REGULATION; DRUG EFFECT; EPIDIDYMIS FAT; EXPERIMENTAL HAMSTER; FECES; HEART WEIGHT; HYPERCHOLESTEROLEMIA; KIDNEY MASS; LIVER SIZE; MALE; MICELLE; NONHUMAN; PERIRENAL FAT; PRIORITY JOURNAL; STEROL EXCRETION; TESTIS WEIGHT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ADIPOSE TISSUE; ADMINISTRATION AND DOSAGE; ANALYSIS; ANIMAL; ANIMAL FOOD; AORTIC DISEASES; ATHEROSCLEROSIS; BIOSYNTHESIS; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; CHOLESTEROL INTAKE; COMPARATIVE STUDY; COMPLICATION; DIET THERAPY; DRUG EFFECTS; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION PROFILING; GENETICS; HAMSTER; INTESTINE ABSORPTION; LIVER; MESOCRICETUS; METABOLISM; ORGAN SIZE; PATHOLOGY; PHARMACOKINETICS; PRECLINICAL STUDY; RANDOMIZATION; VISCERA;

ADIPOSE TISSUE; ANIMAL FEED; ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTIC DISEASES; ATHEROSCLEROSIS; BILE ACIDS AND SALTS; CHOLESTANOL; CHOLESTEROL; CHOLESTEROL, DIETARY; CRICETINAE; DRUG EVALUATION, PRECLINICAL; FECES; GENE EXPRESSION PROFILING; HYPERLIPOPROTEINEMIA TYPE II; INTESTINAL ABSORPTION; LIPIDS; LIPOPROTEINS; LIVER; MALE; MESOCRICETUS; METABOLIC NETWORKS AND PATHWAYS; MICELLES; MOLECULAR STRUCTURE; ORGAN SIZE; PLAQUE, ATHEROSCLEROTIC; RANDOM ALLOCATION; RNA, MESSENGER; SITOSTEROLS; STEROLS; VISCERA;

EID: 84936990627     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.06.046     Document Type: Article

References (28)

1. Grundy S.M. Absorption and metabolism of dietary cholesterol. Annu. Rev. Nutr. 1983, 3:71-96.
2. Grundy S.M., Metzger A.L. Aphysiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology 1972, 62:1200-1217.
3. Armstrong M.J., Carey M.C. Thermodynamic and molecular determinants of sterol solubilities in bile salt micelles. J.Lipid. Res. 1987, 28:1144-1155.
4. Bergmann K.V., Lütjohann D., Lindenthal B., Steinmetz A. Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype. J.Lipid. Res. 2003, 44:193-197.
5. Duchateau G., Cochrane B., Windebank S., Herudzinska J., et al. Absolute oral bioavailability and metabolic turnover of β-sitosterol in healthy subjects. Drug. Metab. Dispos. 2012, 40:2026-2030.
6. De Smet E., Mensink R.P., Plat J. Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present. Mol. Nutr. Food Res. 2012, 56:1058-1072.
7. National Cholesterol Education Program (NCEP) Guidelines on the Detection, Evaluation and Treatment of Elevated Cholesterol in Adults: Adult Treatment Panel III (ATP III) 2002, National Institutes of Health.
8. Myant Nicolas Bruce The Biology of Cholesterol and Related Steroids 2014, Butterworth-Heinemann.
9. Teshima S.I., Kanazawa A. Aconversion of cholesterol to coprostanol and cholestanol in the estuary sediment: kagoshima university repository. Memoirs Fac. Fish. Kagoshima Univ. 1978, 27:41-47.
10. Skrede S., Björkhem I., Buchmann M.S., Hopen G., et al. Anovel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis. J.Clin. Invest. 1985, 75:448-455.
11. Bhattacharyya A.K., Lin D.S., Connor W.E. Cholestanol metabolism in patients with cerebrotendinous xanthomatosis: absorption, turnover, and tissue deposition. J.Lipid Res. 2007, 48:185-192.
12. Ng C.H., Yao X.Q., Huang Y. Oxidised cholesterol is more hypercholesterolaemic and atherogenic than non-oxidised cholesterol in hamsters. Br. J. Nutr. 2008, 99:749-755.
13. Lei L., Liu Y., Wang X., Jiao R., et al. Plasma cholesterol-lowering activity of gingerol- and shogaol-enriched extract is mediated by increasing sterol excretion. J.Agric. Food Chem. 2014, 62:10515-10521.
14. Chan P.T., Fong W.P., Cheung Y.L., Huang Y., et al. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J.Nutr. 1999, 129:1094-1101.
15. Chen J., Jiang Y., Liang Y., Tian X.Y., Peng C., Ma K.Y., Liu J., Huang Y., Chen Z.Y. DPA n-3, DPA n-6 and DHA improve lipoprotein profiles and aortic function in hamsters fed a high cholesterol diet. Atherosclerosis 2012, 221:397-404.
16. Plat J., Nichols J.A., Mensink R.P. Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J.Lipid Res. 2005, 46:2468-2476.
17. De Smet E., Mensink R.P., Plat J. Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present. Mol. Nutr. Food Res. 2012, 56:1058-1072.
18. Siperstein M.D., Nichols C.W., Chaikoff I.L. Prevention of plasma cholesterol elevation and atheromatosis in the cholesterol-fed bird by the administration of dihydrocholesterol. Circulation 1953, 7:37-41.
19. Nichols C.W., Siperstein M.D. Effect of dihydrocholesterol (cholestanol) administration on plasma cholesterol and atherosclerosis in the rabbit. Exp. Biol. Med. 1953, 83:756-758.
20. Ikeda I., Tanaka K., Sugano M., Vahouny G.V., Gallo L.L. Inhibition of cholesterol absorption in rats by plant sterols. J.Lipid Res. 1988, 29:1573-1582.
21. Ikeda I., Tanabe Y., Sugano M. Effects of sitosterol and sitostanol on micellar solubility of cholesterol. J.Nutr. Sci. Vitaminol. (Tokyo). 1989, 35:361-369.
22. Wang X., Huang W., Lei L., Liu Y., et al. Blockage of hydroxyl group partially abolishes the cholesterol-lowering activity of β-sitosterol. J.Funct. Foods. 2015, 12:199-207.
23. Lei L., Wang X., Huang W., Liu Y., et al. Cholesterol side chain analogs but not its ether analogs possess cholesterol-lowering activity. Food Funct. 2014, 10.1039/C4FO01044B.
24. Castro-Torres I.G., De la O-Arciniega M., Bravo-Duarte G.A., Gallegos-Estudillo J., et al. Intestinal and hepatic Niemann-Pick C1L1 proteins: future therapeutic targets for cholesterol gallstones disease?. Eur. J. Pharmacol. 2014, 728:77-81.
25. Ohshiro T., Tomoda H. Acyltransferase inhibitors: a patent review (2010-present). Expert. Opin. Ther. Pat. 2014, 1-14.
26. Yu X.-H., Qian K., Jiang N., Zheng X.L., et al. ABCG5/ABCG8 in cholesterol excretion and atherosclerosis. Clin. Chim. Acta. 2014, 428:82-88.
27. Eberlé D., Hegarty B., Bossard P., Ferré P., Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004, 86:839-848.
28. Parikh M., Patel K., Soni S., Gandhi T. Liver X receptor: a cardinal target for atherosclerosis and beyond. J.Atheroscler. Thromb. 2014, 21:519-531.